Blood filter therapy for sepsis-related kidney injury
Part of Infections, Kidney & urinary clinical trials.
This trial tests a special blood filter (Oxiris) in patients with sepsis who also have acute kidney injury. The filter may help clean the blood better and support kidney recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older, but not over 85.
- You have acute kidney injury caused by sepsis.
- You do not have uncontrolled cancer.
- You are not on dialysis for end-stage kidney disease.
- You do not have severe liver or heart failure requiring advanced support machines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This study looks at how stable blood pressure and heart rhythm are in people with sepsis who need continuous kidney filtration. If you qualify, it may help researchers better improve care for critically ill patients receiving this treatment.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This study tests a special blood-filtering treatment (called Oxiris) for people with septic shock, a life-threatening condition where infection causes very low blood pressure. The goal is to see if this treatment can safely improve recovery. If you are already receiving CRRT, this may help your blood get cleaner and your pressure more stable.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
Hear when a new Sepsis-associated AKI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.